Amphastar Pharmaceuticals
AMPH
#5875
Rank
NZ$2.17 B
Marketcap
NZ$50.95
Share price
3.00%
Change (1 day)
9.75%
Change (1 year)

Operating Margin for Amphastar Pharmaceuticals (AMPH)

Operating Margin as of November 2026 (TTM): 17.55%

According to Amphastar Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 17.55%. At the end of 2022 the company had an Operating Margin of 23.26%.

Operating Margin history for Amphastar Pharmaceuticals from 2013 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202223.26%20.99%
202119.22%1350.08%
20201.33%-92.91%
201918.68%-654.65%
2018-3.37%-598.49%
20170.68%-88.46%
20165.86%-242.15%
2015-4.12%-52.21%
2014-8.62%-214.97%
20137.50%-40.78%
201212.67%-147.01%
2011-26.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Tonix Pharmaceuticals
TNXP
-558.00%-3,279.49%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
20.30% 15.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-446.48%-2,644.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-69.66%-496.92%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.